Non-vascular stents sales will grow through 2036, led by ureteral stents at 38.7% of the product type segment in 2026. Non-metallic stents lead the material type segment with a 52.2% share. The market is projected to reach USD 1.5 billion in 2026 and USD 2.4 billion by 2036.